Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PETERS, Frank T")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 58

  • Page / 3
Export

Selection :

  • and

Stability of analytes in biosamples- : an important issue in clinical and forensic toxicology? : Analytical toxicologyPETERS, Frank T.Analytical and bioanalytical chemistry. 2007, Vol 388, Num 7, pp 1505-1519, 15 p.Article

Recent advances of liquid chromatography―(tandem) mass spectrometry in clinical and forensic toxicologyPETERS, Frank T.Clinical biochemistry. 2011, Vol 44, Num 1, pp 54-65, issn 0009-9120, 12 p.Article

Systematic comparison of bias and precision data obtained with multiple-point and one-point calibration in six validated multianalyte assays for quantification of drugs in human plasmaPETERS, Frank T; MAURER, Hans H.Analytical chemistry (Washington, DC). 2007, Vol 79, Num 13, pp 4967-4976, issn 0003-2700, 10 p.Article

Bioanalytical method validation and its implications for forensic and clinical toxicology: A reviewPETERS, Frank T; MAURER, Hans H.Accreditation and quality assurance. 2002, Vol 7, Num 11, pp 441-449, issn 0949-1775, 9 p.Article

Drug testing in blood: Validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for determination of amphetamine and methamphetamine enantiomers and its application to toxicology casesPETERS, Frank T; KRAEMER, Thomas; MAURER, Hans H et al.Clinical chemistry (Baltimore, Md.). 2002, Vol 48, Num 9, pp 1472-1485, issn 0009-9147Article

Analytical Toxicology of Emerging Drugs of AbusePETERS, Frank T; MARTINEZ-RAMIREZ, Jorge A.Therapeutic drug monitoring. 2010, Vol 32, Num 5, pp 532-539, issn 0163-4356, 8 p.Conference Paper

Analytical Toxicology of Emerging Drugs of Abuse—An UpdateMEYER, Markus R; PETERS, Frank T.Therapeutic drug monitoring. 2012, Vol 34, Num 6, pp 615-621, issn 0163-4356, 7 p.Article

The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-MethylenedioxyMethamphetamine and Its EnantiomersMEYER, Markus R; PETERS, Frank T; MAURER, Hans H et al.Drug metabolism and disposition. 2008, Vol 36, Num 11, pp 2345-2354, issn 0090-9556, 10 p.Article

Detection and validated quantification of toxic alkaloids in human blood plasma - : comparison of LC-APCI-MS with LC-ESI-MS/MSBEYER, Jochen; PETERS, Frank T; KRAEMER, Thomas et al.Journal of mass spectrometry. 2007, Vol 42, Num 5, pp 621-633, issn 1076-5174, 13 p.Article

Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS/MS with electrospray ionizationBEYER, Jochen; PETERS, Frank T; KRAEMER, Thomas et al.Journal of mass spectrometry. 2007, Vol 42, Num 2, pp 150-160, issn 1076-5174, 11 p.Article

Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomersMEYER, Markus R; PETERS, Frank T; MAURER, Hans H et al.Biochemical pharmacology. 2009, Vol 77, Num 11, pp 1725-1734, issn 0006-2952, 10 p.Article

Automated Mass Spectral Deconvolution and Identification System for GC-MS Screening for Drugs, Poisons, and Metabolites in UrineMEYER, Markus R; PETERS, Frank T; MAURER, Hans H et al.Clinical chemistry (Baltimore, Md.). 2010, Vol 56, Num 4, pp 575-584, issn 0009-9147, 10 p.Article

Investigations on the human hepatic cytochrome P450 isozymes involved in the metabolism of 3,4-methylenedioxy-amphetamine (MDA) and benzodioxolyl-butanamine (BDB) enantiomersMEYER, Markus R; PETERS, Frank T; MAURER, Hans H et al.Toxicology letters. 2009, Vol 190, Num 1, pp 54-60, issn 0378-4274, 7 p.Article

The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxyethylamphetamine and Its Single EnantiomersMEYER, Markus R; PETERS, Frank T; MAURER, Hans H et al.Drug metabolism and disposition. 2009, Vol 37, Num 6, pp 1152-1156, issn 0090-9556, 5 p.Article

Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic NeurotoxicityMUELLER, Melanie; JIE YUAN; FELIM, Anne et al.Drug metabolism and disposition. 2009, Vol 37, Num 10, pp 2079-2086, issn 0090-9556, 8 p.Article

Studies on the metabolism and toxicological detection of the new designer drug 4'-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometrySPRINGER, Dietmar; PETERS, Frank T; FRITSCHI, Giselher et al.Journal of chromatography. B, Biomedical sciences and applications. 2002, Vol 773, Num 1, pp 25-33, issn 1387-2273Conference Paper

Biotechnological synthesis of drug metabolites using human cytochrome P450 2D6 heterologously expressed in fission yeast exemplified for the designer drug metabolite 4'-hydroxymethyl-α-pyrrolidinobutyrophenonePETERS, Frank T; DRAGAN, Calin-A; WILDE, Desirée R et al.Biochemical pharmacology. 2007, Vol 74, Num 3, pp 511-520, issn 0006-2952, 10 p.Article

Validation of new methodsPETERS, Frank T; DRUMMER, Olaf H; MUSSHOFF, Frank et al.Forensic science international. 2007, Vol 165, Num 2-3, pp 216-224, issn 0379-0738, 9 p.Article

Drug testing in blood : Validated negative-ion chemical lonization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMAPETERS, Frank T; SAMYN, Nele; LAMERS, Caroline T. J et al.Clinical chemistry (Baltimore, Md.). 2005, Vol 51, Num 10, pp 1811-1822, issn 0009-9147, 12 p.Article

Negative ion chemical ionization gas chromatography-mass spectrometry and atmospheric pressure chemical ionization liquid chromatography-mass spectrometry of low-dosed and/or polar drugs in plasmaMAURER, Hans H; KRAEMER, Thomas; KRATZSCH, Carsten et al.Therapeutic drug monitoring. 2002, Vol 24, Num 1, pp 117-124, issn 0163-4356Conference Paper

Convenient Gram-Scale Metabolite Synthesis by Engineered Fission Yeast Strains Expressing Functional Human P450 SystemsDRAGAN, Călin-Aurel; PETERS, Frank T; BUREIK, Matthias et al.Applied biochemistry and biotechnology. 2011, Vol 163, Num 8, pp 965-980, issn 0273-2289, 16 p.Article

Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamineSAUER, Christoph; PETERS, Frank T; SCHWANINGER, Andrea E et al.Biochemical pharmacology. 2009, Vol 77, Num 3, pp 444-450, issn 0006-2952, 7 p.Article

Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brainMUELLER, Melanie; PETERS, Frank T; RICAURTE, George A et al.Journal of chromatography. B. 2008, Vol 874, Num 1-2, pp 119-124, issn 1570-0232, 6 p.Article

Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometrySAUER, Christoph; PETERS, Frank T; STAACK, Roland F et al.Forensic science international. 2008, Vol 181, Num 1-3, pp 47-51, issn 0379-0738, 5 p.Article

Comparison of urinary on-site immunoassay screening and gas chromatography-mass spectrometry results of 111 patients with suspected poisoning presenting at an emergency departmentVON MACH, Marc-A; WEBER, Carola; MEYER, Markus R et al.Therapeutic drug monitoring. 2007, Vol 29, Num 1, pp 27-39, issn 0163-4356, 13 p.Article

  • Page / 3